XML 21 R6.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Jan. 02, 2026
Jan. 03, 2025
Dec. 29, 2023
Operating Activities      
Net income $ 1,606 $ 1,512 $ 1,198
Adjustments to reconcile to net cash provided by operating activities:      
Depreciation and amortization 1,224 1,289 1,166
Share-based compensation 113 97 89
Net periodic benefit income (330) (286) (275)
Share-based matching contributions under defined contribution plans 253 264 231
Impairment of goodwill and other assets 85 38 374
Deferred income taxes 206 174 (423)
(Increase) decrease in:      
Receivables, net (343) 128 124
Contract assets (437) (194) 62
Inventories, net 117 96 (182)
Other current assets 17 (29) (55)
Increase (decrease) in:      
Accounts payable 475 (90) 87
Contract liabilities 181 126 195
Compensation and benefits 70 (128) 38
Other current liabilities (423) 155 (88)
Income taxes 365 (383) (333)
Other operating activities (73) (210) (112)
Net cash provided by operating activities 3,106 2,559 2,096
Investing Activities      
Net cash paid for acquired businesses 0 0 (6,688)
Capital expenditures (424) (408) (449)
Proceeds from sales of businesses, net of cash divested 820 273 71
Other investing activities 11 (128) 45
Net cash provided by (used in) investing activities 407 (263) (7,021)
Financing Activities      
Proceeds from issuances of long-term debt, net 0 2,827 7,568
Repayments of long-term debt (618) (2,620) (3,170)
Change in commercial paper, maturities under 90 days, net (515) (567) 623
Proceeds from commercial paper, maturities over 90 days 0 688 1,181
Repayments of commercial paper, maturities over 90 days 0 (1,205) (205)
Repurchases of common stock (1,154) (554) (518)
Dividends paid (903) (886) (868)
Other financing activities 108 93 (17)
Net cash (used in) provided by financing activities (3,082) (2,224) 4,594
Effect of exchange rate changes on cash and cash equivalents 23 (17) 11
Net increase (decrease) in cash and cash equivalents 454 55 (320)
Cash and cash equivalents, beginning of period 615 560 880
Cash and cash equivalents, end of period $ 1,069 $ 615 $ 560